UK markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.56+0.45 (+3.00%)
As of 01:39PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate1.36-0.910.48-0.76
Low estimate-0.81-1.09-1.21-2.18
High estimate2.67-0.681.860.18
Year ago EPS0.58-1.26-5.410.48
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate414.82M51.45M995.57M422.75M
Low estimateN/A35M810M50M
High estimate585M75M1.13B601.9M
Year ago salesN/A186.99M983.71M995.57M
Sales growth (year/est)N/A-72.50%1.20%-57.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.39-1.83-0.45-1.06
Actual EPS0.58-1.26-1.44-1.05
Difference1.970.57-0.990.01
Surprise %141.70%31.10%-220.00%0.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate1.36-0.910.48-0.76
7 days ago0.92-0.850.13-0.99
30 days ago-0.85-0.77-0.72-0.04
60 days ago-1.03-0.91-0.80.12
90 days ago-1.29-1.11-0.550.14
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2N/A22
Up last 30 days3142
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A1N/AN/A
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.134.50%N/AN/AN/A
Next qtr.27.80%N/AN/AN/A
Current year108.90%N/AN/AN/A
Next year-258.30%N/AN/AN/A
Next 5 years (per annum)37.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A